[{"id":"88a56803-e53e-402f-8615-d502f691f9f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT04682665","created_at":"2021-01-19T20:46:58.736Z","updated_at":"2024-07-02T16:35:27.981Z","phase":"","brief_title":"Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases","source_id_and_acronym":"NCT04682665","lead_sponsor":"University of Leeds","biomarkers":" PD-1 • CTLA4 • TIGIT • CCL2","pipe":"","alterations":" ","tags":["PD-1 • CTLA4 • TIGIT • CCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e icosapent ethyl"],"overall_status":"Recruiting","enrollment":" Enrollment 250","initiation":"Initiation: 09/16/2021","start_date":" 09/16/2021","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2023-11-28"},{"id":"acaf9a0f-a467-43c2-8f34-dc61f9d4f9d3","acronym":"OMICC","url":"https://clinicaltrials.gov/study/NCT03661047","created_at":"2021-01-18T17:57:51.957Z","updated_at":"2024-07-02T16:36:20.624Z","phase":"Phase 2","brief_title":"OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer","source_id_and_acronym":"NCT03661047 - OMICC","lead_sponsor":"Massachusetts General Hospital","biomarkers":" PD-L1 • CD8 • PD-1 • IL6 • LAG3 • TNFA • CTLA4 • HAVCR2 • TIGIT • IL10 • CCL2 • FOXP3 • ITGA2","pipe":"","alterations":" ","tags":["PD-L1 • CD8 • PD-1 • IL6 • LAG3 • TNFA • CTLA4 • HAVCR2 • TIGIT • IL10 • CCL2 • FOXP3 • ITGA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e icosapent ethyl"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 11/30/2019","start_date":" 11/30/2019","primary_txt":" Primary completion: 11/30/2021","primary_completion_date":" 11/30/2021","study_txt":" Completion: 11/30/2021","study_completion_date":" 11/30/2021","last_update_posted":"2021-11-17"}]